Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions.

PloS One
Déborah Tribouillard-TanvierMarc Blondel

Abstract

Prion-based diseases are incurable transmissible neurodegenerative disorders affecting animals and humans. Here we report the discovery of the in vivo antiprion activity of Guanabenz (GA), an agonist of alpha2-adrenergic receptors routinely used in human medicine as an antihypertensive drug. We isolated GA in a screen for drugs active in vivo against two different yeast prions using a previously described yeast-based two steps assay. GA was then shown to promote ovine PrP(Sc) clearance in a cell-based assay. These effects are very specific as evidenced by the lack of activity of some GA analogues that we generated. GA antiprion activity does not involve its agonist activity on alpha2-adrenergic receptors as other chemically close anti-hypertensive agents possessing related mechanism of action were found inactive against prions. Finally, GA showed activity in a transgenic mouse-based in vivo assay for ovine prion propagation, prolonging slightly but significantly the survival of treated animals. GA thus adds to the short list of compounds active in vivo in animal models for the treatment of prion-based diseases. Because it has been administrated for many years to treat hypertension on a daily basis, without major side-effects, o...Continue Reading

References

Aug 5, 1989·Lancet·R Levy
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R GabizonS B Prusiner
Aug 1, 1984·The Journal of General Virology·B Ehlers, H Diringer
Jun 1, 1982·Southern Medical Journal·M C Houston
Jul 12, 1995·Annals of the New York Academy of Sciences·S G SchäferG J Molderings
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·G C TellingS B Prusiner
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·S SupattaponeM R Scott
Mar 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·D ViletteH Laude
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·C KorthS B Prusiner
Aug 1, 2002·Proceedings of the National Academy of Sciences of the United States of America·Gianluigi ForloniFabrizio Tagliavini
Sep 27, 2002·Annals of Neurology·Steven J CollinsColin L Masters
Apr 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·Carsten KorthStanley B Prusiner
Jul 15, 2003·Journal of Virology·A BarretJ P Deslys
Aug 12, 2003·Nature Biotechnology·Stéphane BachMarc Blondel
Nov 25, 2003·The American Journal of Pathology·Yuzuru TaguchiTetsuyuki Kitamoto
Dec 13, 2003·Journal of Virology·Fabienne ArcherHubert Laude
Mar 5, 2004·Journal of Medicinal Chemistry·Camille G Wermuth
Dec 25, 2004·The Journal of Biological Chemistry·Cécile FéraudetJacques Grassi
Oct 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Annick Le DurHubert Laude
Jun 6, 2006·Methods : a Companion to Methods in Enzymology·Stéphane BachMarc Blondel
Jul 4, 2006·Brain : a Journal of Neurology·Clare R Trevitt, John Collinge
Aug 8, 2006·Biotechnology Journal·Déborah TribouillardMarc Blondel
Aug 12, 2006·Fungal Genetics and Biology : FG & B·Laura Benkemoun, Sven J Saupe
May 9, 2007·The Journal of Clinical Hypertension·Domenic A Sica
Jun 19, 2007·Journal of Molecular Biology·Sabine GilchHermann M Schätzl
Sep 7, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sevda DirikocJoëlle Chabry
Dec 13, 2007·Veterinary Research·Didier Vilette

❮ Previous
Next ❯

Citations

Jun 4, 2014·PloS One·Christiane NeuberThomas Eschenhagen
Jun 14, 2014·European Journal of Medicinal Chemistry·Phuhai NguyenCécile Voisset
Apr 8, 2014·Antioxidants & Redox Signaling·Stewart Siyan Cao, Randal J Kaufman
Jul 23, 2009·Expert Review of Anti-infective Therapy·Marcus W BrazierSteven J Collins
Oct 25, 2014·Viruses·Debapriya Banerjee, Suparna Sanyal
Feb 17, 2015·Expert Opinion on Drug Discovery·Maria Laura Bolognesi, Giuseppe Legname
Apr 10, 2013·Neurobiology of Disease·Alexandra VaccaroJ Alex Parker
Sep 21, 2013·Drug Discovery Today. Technologies·Aymeric Chartier, Martine Simonelig
Jun 23, 2015·Cell Reports·Meng S ChoyWolfgang Peti
Aug 7, 2008·Biotechnology Journal·Cécile VoissetMarc Blondel
Feb 22, 2012·The FEBS Journal·Pavel Tsaytler, Anne Bertolotti
May 14, 2011·Biotechnology Journal·Cécile VoissetMarc Blondel
Nov 19, 2011·Wiley Interdisciplinary Reviews. RNA·Mariana P B GomesJerson L Silva
Feb 23, 2011·Wiley Interdisciplinary Reviews. RNA·Reed B WicknerDavid Bateman
Sep 25, 2015·Nucleic Acids Research·Maire F OsbornAnastasia Khvorova
Apr 9, 2015·Acta Neuropathologica Communications·Joan TorrentHuman Rezaei
Mar 4, 2014·Biochimica Et Biophysica Acta·Cécile VoissetRalf Erik Wellinger
Dec 30, 2014·Médecine sciences : M/S·Cécile Voisset, Marc Blondel
Jun 22, 2013·Prion·Robert A Somerville
Aug 20, 2015·PloS One·Fernando G VieiraSteven Perrin
Aug 27, 2013·PloS One·Nassima OumataCécile Voisset
Sep 21, 2016·Expert Opinion on Therapeutic Patents·Jeffrey M Axten
Sep 17, 2016·Scientific Reports·Marc BlondelCécile Voisset
Aug 2, 2017·Nature Structural & Molecular Biology·Marta CarraraAnne Bertolotti
Jan 17, 2019·Human Molecular Genetics·Alberto MalerbaCapucine Trollet
Sep 11, 2019·Organic & Biomolecular Chemistry·Sumit S ChourasiyaPrasad V Bharatam

❮ Previous
Next ❯

Methods Mentioned

BETA
Cyclic Amplification assay
transgenic

Software Mentioned

GeneTools

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.